Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index; 11 of the 21 sources its claims cite were checked for support.
Abstract
Adeno-associated virus (AAV) vectors can deliver transgenes to diverse cell types and are therefore useful for basic research and gene therapy. Although AAV has many advantages over other viral vectors, its relatively small packaging capacity limits its use for delivering large genes. The available transgene size is further limited by the existence of additional elements in the expression cassette without which the gene expression level becomes much lower. By using alternative combinations of shorter elements, we generated a series of AAV expression cassettes and systematically evaluated their expression efficiency in neurons to maximize the transgene size available within the AAV packaging capacity while not compromising the transgene expression. We found that the newly developed smaller expression cassette shows comparable expression efficiency with an efficient vector generally used for strong gene expression. This new expression cassette will allow us to package larger transgenes without compromising expression efficiency.
Overview
CoChat Summary
TL;DR
This study systematically shortened AAV expression-cassette elements and identified CW3SL, a cassette ~399 bp smaller than the prototype CWB that drives comparable transgene expression. CW3SL increased AAV packaging capacity, allowing expression of a 5.2 kb p110γ-EGFP cassette that exceeded the conventional AAV packaging limit in the CWB context.
Key findings
- Replacing 600 bp WPRE with 247 bp WPRE3 (CW3B) gave EGFP expression at 83.4% of CWB, not statistically different from CWB; removing WPRE (CB) reduced expression to 28.6%, and a chimeric intron (CIB) gave 16.6%.
- Among polyadenylation variants, CW3SL (WPRE3 plus SV40 late polyadenylation signal upstream element and SV40 late polyadenylation signal) produced 122.7% of CW3B expression in vitro and 103.4% of parental CWB, while CW3A (synthetic polyadenylation signal alone) was only 49.7% of CW3B and 40.4% of CWB.
- In mouse hippocampal CA1, CW3SL-EGFP expression was 86.2% of CWB-EGFP.
- For p110γ-EGFP, CWB produced a 5.6 kb packaged genome exceeding the 5.2 kb AAV limit, whereas CW3SL produced a 5.2 kb genome; viral titers were comparable (6.61 × 10^12 GC/ml for CWB vs. 7.01 × 10^12 GC/ml for CW3SL), but CW3SL drove five times more p110γ-EGFP expression than CWB.
Methods
- A series of AAV expression cassettes was generated by replacing WPRE and bGHpA with shorter elements, cloned between ITRs, and used to produce AAV serotype 1 in HEK293T cells; vectors were purified by iodixanol gradients and titered by quantitative RT-PCR.
- Cultured hippocampal neurons from E18 rat embryos were co-infected with EGFP and tdTomato AAVs; EGFP expression was quantified by western blot and normalized to tdTomato. In vivo, AAVs were stereotactically injected into mouse hippocampal CA1, and EGFP fluorescence was normalized to tdTomato by confocal imaging.
- Statistical comparisons used ANOVA with Bonferroni post-hoc tests; mouse hippocampal transcript length distributions were analyzed from RNA sequencing data.
Limitations
- The paper does not include a formal limitations section; it notes that cassettes shorter than CW3SL would allow packaging even longer transgenes but with lower expression levels.
- Evident from the text: in vivo CW3SL expression was slightly weaker than CWB (86.2%) in mouse CA1.
- Evident from the text: neuronal expression tests used the CaMKIIα promoter and hippocampal neurons; the authors suggest substituting other promoters or cell-type-specific promoters but do not test these alternatives.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
5 Valid · 2 Not valid · 4 Not checked · 27 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Efforts have been made to expand the available AAV transgene size by trans-splicing and/or recombination to split the AAV expression cassette to two viral vectors [9]. However, the expression efficiency is still much lower than that of a single viral vector.”
- Also stated in: § Discussion · plain
“Techniques to divide a gene into two AAV vectors and then combining each segment to reconstitute the full-length sequence after transduction by trans-splicing and recombination have been developed, but this technique is still in its infancy showing much lower expression efficiency compared to a non-divided single vector [9].”
§ Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons > Background
What the sources say
- Disputedcites [9] Ghosh A, Yue Y, Duan D: Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences. Hum Gene Ther. 2011, 22: 77-83. 10.1089/hum.2010.122. sourceExperimental — accuracy not yet measured
The Discussion says trans-splicing and overlapping dual vectors have achieved expression comparable to a single AAV for certain genes, contrary to the claim that their expression is much lower. It cautions that success depends on the target gene, but does not make the claimed general comparison. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“other studies [6-8] indicated that intact genomes were not, in fact, packaged in that case [3], and further suggested a strict size cutoff of 5.2 kb.”
- Also stated in: § CW3SL significantly increases AAV packaging limit of transgene · plain
“which exceeds the 5.2 kb packaging limit for AAV.”
§ Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons > Background
What the sources say
- Partly supportedcites [6] Dong B, Nakai H, Xiao W: Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther J Am Soc Gene Ther. 2010, 18: 87-92. 10.1038/mt.2009.258. sourceExperimental — accuracy not yet measured
The Discussion supports a physical limit on AAV genome packaging, but gives the limit as less than 5 kb and concludes that a capsid cannot accommodate more than 5,000 nucleotides. It does not support the claimed strict cutoff of 5.2 kb. (LLM, conf=0.88)
- Supportedcites [7] Wu Z, Yang H, Colosi P: Effect of genome size on AAV vector packaging. Mol Ther J Am Soc Gene Ther. 2010, 18: 80-86. 10.1038/mt.2009.255. source
The Results report that genomes from vectors larger than 5.2 kb were truncated and that the upper packaging limit for the AAV2 and AAV5 capsids tested appeared to be approximately 5.2 kb. The Discussion reports the same maximum for the AAV2, AAV5, and AAV8 vectors tested, supporting the citing sentence’s suggestion of a cutoff rather than an absolute claim about every AAV vector. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [8] Lai Y, Yue Y, Duan D: Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb. Mol. Ther J Am Soc Gene Ther. 2010, 18: 75-79. 10.1038/mt.2009.256. source
- Not checked — no full text of the sourcecites [3] Dong JY, Fan PD, Frizzell RA: Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther. 1996, 7: 2101-2112. 10.1089/hum.1996.7.17-2101. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § CW3SL significantly increases AAV packaging limit of transgene · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Conventionally used AAV backbones which include a commonly used neuronal expression cassette composed of 1.3 kb CaMKIIα promoter (which shows comparable expression efficiency with 0.4 kb CaMKIIα promoter [10] used in CWB), WPRE, and human growth hormone polyadenylation signal [23-25] has a capacity of 2.4 kb.”
§ Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons > Discussion
What the sources say
- Partly supportedcites [10] Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, Helmchen F, Denk W, Brecht M, Osten P: Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci. 2004, 101: 18206-18211. 10.1073/pnas.0407976101. sourceExperimental — accuracy not yet measured
Table 1 (Methods, p. 2) identifies a 1.3-kb α-CaMKII promoter used in this paper’s lentiviral vectors. The Discussion (p. 6) gives an approximately 10-kb limit for a lentiviral promoter-and-gene cassette, not a 2.4-kb capacity for an AAV backbone. The cited passages do not establish the claimed AAV cassette with WPRE and a human growth hormone polyadenylation signal. (LLM, conf=0.89)
- Partly supportedcites [23] Tye KM, Prakash R, Kim S-Y, Fenno LE, Grosenick L, Zarabi H, Thompson KR, Gradinaru V, Ramakrishnan C, Deisseroth K: Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011, 471: 358-362. 10.1038/nature09820. sourceExperimental — accuracy not yet measured
The Methods Summary (Virus-mediated opsin gene expression; page not provided) describes AAV5-packaged plasmids using a CaMKIIα promoter. It does not specify a 1.3 kb promoter, WPRE, a human growth hormone polyadenylation signal, or a 2.4 kb capacity; searches for those cassette components and capacity found no supporting passage. (LLM, conf=0.82)
- Partly supportedcites [24] Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O’Shea DJ, Sohal VS, Goshen I, Finkelstein J, Paz JT, Stehfest K, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P, Deisseroth K: Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011, 477: 171-178. 10.1038/nature10360. sourceExperimental — accuracy not yet measured
The Consequences of altered E/I balance section describes an AAV expressing SSFO–EYFP under a CaMKIIα promoter, supporting the use of that promoter in an AAV construct. The passages do not specify a 1.3 kb promoter, WPRE, a human growth hormone polyadenylation signal, or a 2.4 kb capacity; searches for those terms found no supporting passage. Page numbers were unavailable in our copy. (LLM, conf=0.83)
- Partly supportedcites [25] Mattis J, Tye KM, Ferenczi EA, Ramakrishnan C, O’Shea DJ, Prakash R, Gunaydin LA, Hyun M, Fenno LE, Gradinaru V, Yizhar O, Deisseroth K: Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nat Methods. 2012, 9: 159-172. sourceExperimental — accuracy not yet measured
The Results section (‘Inhibiting spikes in pyramidal cells in acute slice’; page not provided) describes an AAV construct controlled by a CaMKIIα promoter. Online Methods (‘Molecular cloning’; page not provided) mentions WPRE, but for lentiviral constructs. Our copy does not give a 1.3 kb promoter length, identify a human growth hormone polyadenylation signal in that AAV backbone, or state a 2.4 kb capacity. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“which shows comparable expression efficiency with 0.4 kb CaMKIIα promoter [10] used in CWB”
§ Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons > Discussion
What the sources say
- Supportedcites [10] Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, Helmchen F, Denk W, Brecht M, Osten P: Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci. 2004, 101: 18206-18211. 10.1073/pnas.0407976101. source
The Results (p. 3) identify the 0.4-kb and 1.3-kb α-CaMKII vectors as producing the strongest EGFP expression. Figure 1 on the same page reports similar normalized expression values for them—155.1 ± 7.9 and 165.7 ± 13.5, respectively—in the tested cortical neurons. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although CWB-p110γ-EGFP did produce comparable amount of virus (6.61 × 1012 GC/ml for CWB-p110γ-EGFP, 7.01 × 1012 GC/ml for CW3SL-p110γ-EGFP; GC: genome copy)”
§ Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons > Results > CW3SL significantly increases AAV packaging limit of transgene
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
23 more claims
Create a free account to see all 38 claims and every source verdict.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A shorter version of the WPRE (WPRE3; 247 bp) showed only a 15% drop in expression in hippocampal neuron cultures or GFP expression in rAAV infected hippocampal CA1 region in the mouse brain [139].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The SV40 late polyadenylation signal upstream element and the SV40 late polyadenylation signal combined with the WPRE3 (420 bp), decrease the length to less than half compared to the commonly used WPRE-bGHpolyA gene cassette (919 bp), and maintain a similar expression profile [139].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Woodchuck Hepatitis Virus PRE (WPRE) | 600 | +++, 6-10× increase | [139,150]”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SV40 late | 135 | +++ | [139]”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [139]
Experimental — accuracy not yet measured
Citations
Cites
Neocortical excitation/inhibition balance in information processing and social dysfunction
Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454 · cited 1×
“4 kb CaMKIIα promoter [10] used in CWB), WPRE, and human growth hormone polyadenylation signal [23-25] has a capacity of 2.”
MethodAmygdala circuitry mediating reversible and bidirectional control of anxiety
Tye, K. M., Prakash, R., Kim, S.-Y., Fenno, L. E., Grosenick, L., Zarabi, H., Thompson, K. R., Gradinaru, V., Ramakrishnan, C., & Deisseroth, K. (2011) · Nature · doi:10.1038/nature09820 · Cited by 1,289 · cited 1×
“4 kb CaMKIIα promoter [10] used in CWB), WPRE, and human growth hormone polyadenylation signal [23-25] has a capacity of 2.”
MethodEffect of genome size on AAV vector packaging
Wu, Z., Yang, H., & Colosi, P. (2010) · Molecular Therapy · doi:10.1038/mt.2009.255 · Cited by 1,029
Mattis, J., Tye, K. M., Ferenczi, E. A., Ramakrishnan, C., O'Shea, D. J., Prakash, R., Gunaydin, L. A., Hyun, M., Fenno, L. E., Gradinaru, V., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1808 · Cited by 780
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583 · cited 2×
“Although there is a report describing specific serotypes with much larger packaging capacity [5], other studies [6-8] indicated that intact genomes were not, in fact, packaged in that case [3], and further suggested a strict size cutoff of 5.”
BackgroundDittgen, T., Nimmerjahn, A., Komai, S., Licznerski, P., Waters, J., Margrie, T. W., Helmchen, F., Denk, W., Brecht, M., & Osten, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407976101 · Cited by 485
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350 · cited 2×
“1, and WPRE3 was produced by using recombinant PCR, in which the minimal sequences of γ and α elements were fused [16].”
BackgroundMethod(2013) · PubMed · Cited by 308
Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA
Huang, M. T. F., & Gorman, C. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.4.937 · Cited by 303 · cited 1×
“Introns are known to possess a posttranscriptional regulatory element that efficiently induces transport of mRNA out of the nucleus and enhances mRNA stability [18].”
BackgroundAllocca, M., Doria, M., Petrillo, M., Colella, P., Garcia-Hoyos, M., Gibbs, D., Kim, S. R., Maguire, A., Rex, T. S., Di Vicino, U., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34316 · Cited by 292
Cited by
Emerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
A viral strategy for targeting and manipulating interneurons across vertebrate species
Dimidschstein, J., Chen, Q., Tremblay, R., Rogers, S. L., Saldi, G.-A., Guo, L., Xu, Q., Liu, R., Lu, C., Chu, J., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4430 · Cited by 541
Levy, J. M., Yeh, W.-H., Pendse, N., Davis, J. R., Hennessey, E., Butcher, R., Koblan, L. W., Comander, J., Liu, Q., & Liu, D. R. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0501-5 · Cited by 477
Systemic AAV vectors for widespread and targeted gene delivery in rodents
Challis, R. C., Ravindra Kumar, S., Chan, K. Y., Challis, C., Beadle, K., Jang, M. J., Kim, H. M., Rajendran, P. S., Tompkins, J. D., Shivkumar, K., et al. (2019) · Nature Protocols · doi:10.1038/s41596-018-0097-3 · Cited by 409
Metadata
- Authors
- Choi, J.-H., Yu, N.-K., Baek, G.-C., Bakes, J., Seo, D., Nam, H. J., Baek, S. H., Lim, C.-S., Lee, Y.-S., & Kaang, B.-K.
- Affiliations
- Seoul National University (KR)
- Chung-Ang University (KR)
- Corresponding author
- Kaang, Bong-Kiun
- ORCID
- Venue
- Molecular Brain
- Published
- 2014-03-11
- Volume
- 7
- Issue
- 1
- Pages
- 17-17
- ISSN
- 1756-6606 (ISSN-L)
- PMC
- PMC3975461
- OpenAlex
- W2144605372
- Cited by
- 188
- References
- 27
- Citations by year
- 2026: 26 · 2025: 24 · 2024: 23 · 2023: 19 · 2022: 16 · 2021: 15 · 2020: 17 · 2019: 11 · 2018: 11 · 2017: 13 · 2016: 6 · 2015: 6
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Brain (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- adeno-associated virus vectors, packaging capacity, transgene expression efficiency, neurons, gene therapy vectors, multi-objective optimization
- MeSH terms
- Dependovirus, Animals, Brain, Genetic Techniques, Genetic Vectors, Humans, Male, Mice, Inbred C57BL, Neurons, Regulatory Sequences, Nucleic Acid, Gene Expression, Sequence Deletion, Virus Assembly, Transgenes, Polyadenylation, Mice, Rats, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons. https://app.cochat.ai/papers/10.1186/1756-6606-7-17
- The paper
- Choi, J.-H., Yu, N.-K., Baek, G.-C., Bakes, J., Seo, D., Nam, H. J., Baek, S. H., Lim, C.-S., Lee, Y.-S., & Kaang, B.-K. (2014). Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons. Molecular Brain. https://doi.org/10.1186/1756-6606-7-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.